BeOne Medicines has extended its relationship with Blood Cancer United, committing $5 million over three years to support the ...

Driven by personal losses, major unmet needs and a desire to diversify from the crowded oncology market, Fosun Pharma is ...

Biogen is running a campaign aimed at spreading awareness of the next-gen version of its spinal muscular atrophy therapy Spinraza.  | Biogen is running a campaign aimed at spreading awareness of the ...

Bayer has scored a key victory in its defense against Roundup lawsuits as the U.S. Supreme Court has tossed a $1.25 million ...

With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is ...

The FDA has accused Pinnacle Biologics of creating videos that make it hard for healthcare professionals to “adequately ...

After 35 years engaged in the research and development of pharmaceutical products, Ionis began marketing its drugs for the ...

AstraZeneca has partnered with YMCA of the USA (Y-USA) to increase awareness of cancer screening and early detection. Now in ...

After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...

German generics maker Stada is back to business after being acquired by CapVest Partners last year, loading itself up with 16 ...

AdvanCell, a clinical-stage radiopharmaceutical developer, has inked a lease near Boston to produce its prostate cancer ...

He added that the company's plan to sell Foundayo through government channels will depend on the pricing implications of the ...